21 results
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
and expenses Apexigen may incur due to injuries to Apexigen’s employees resulting from the use of hazardous materials, this insurance may not provide
S-4/A
mybyi9xi
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
xffnbkj
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
10-K
kmfrefhe26w2s6p
29 Mar 22
Annual report
7:36am
10-Q
id6ifnipv
15 Nov 21
Quarterly report
7:54am
424B4
903l7gq
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1/A
EX-10.15
ql4bocqp7kiiim0o
30 Sep 21
IPO registration (amended)
9:11pm
S-1
5dg4gwm76yb 3fb
17 Sep 21
IPO registration
5:00pm
DRS/A
zsqy7m szujokd7
10 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
gjecspvgcxnqqfdh
4 Aug 21
Draft registration statement (amended)
12:00am